Live Cell Imaging Market

Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), Technology (Time-lapse Microscopy, FRET, FRAP, HCS), End User (Pharma, Biotech, CROs) - Global Forecast to 2028

Report Code: BT 3390 Oct, 2020, by marketsandmarkets.com

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !

Updated on : February 20, 2023

The global live cell imaging market in terms of revenue was estimated to be worth $1.8 billion in 2020 and is poised to reach $2.8 billion by 2025, growing at a CAGR of 8.8% from 2020 to 2025. Growing adoption of high-content screening techniques in drug discovery and rising incidence of cancer primarily drives the market for live cell imaging. The growth in research funding and rising government funding and investment in regenerative medicine research will also support the market growth in the coming years. However, the high cost of high-content screening systems is limiting the overall adoption of these products.

Attractive Opportunities In The Live Cell Imaging Market

To know about the assumptions considered for the study, Request for Free Sample Report

Live Cell Imaging Market Dynamics

Drivers: Growing adoption of high-content screening techniques in drug discovery

The traditional method of toxicity and drug safety studies involves the screening of large libraries through high-throughput screening. This method is expensive, has a low success rate, and is resource- and time-consuming. To overcome these challenges, pharmaceutical companies are increasingly adopting high-content screening (HCS) cell-based assays for identifying the effects of toxicity in drug development studies (cell-based imaging enables the monitoring of drug toxicity mechanisms, such as oxidative stress, micronuclei, mitochondrial dysfunction, steatosis, and apoptosis). The use of HCS makes the drug development process more time- and cost-efficient. Owing to these factors, the adoption of high-content screening for toxicity studies is expected to increase during the forecast period. This, in turn, is expected to drive market growth as live cell imaging is used in HCS to identify meaningful information from complex systems such as in vitro, in vivo, and ex vivo systems. 

Restraints: High cost of high-content screening systems

High-content screening (HCS) instruments are equipped with advanced features and functionalities and are, therefore, priced at a premium. A confocal microscope, for instance, can cost more than USD 250,000, and a wide-field microscope can cost more than USD 100,000. Similarly, the InCell 2000 Analyzer system (from GE Healthcare) used in HCS costs around USD 240,000. Academic research laboratories find it difficult to afford such high-priced instruments as they have restricted budgets. The high price of these instruments is also a concern for several pharmaceutical companies as they require multiple HCS systems in their R&D activities (thus increasing the total cost spent on these systems). In addition to the high procurement costs, the maintenance costs and several other indirect expenses increase the total cost of ownership of these instruments. This is one of the major factors limiting the adoption of live cell imaging instruments in clinical and research applications, especially in emerging countries. 

Opportunities: Untapped potential of emerging markets

Emerging markets such as Brazil, Russia, India, and China are expected to offer significant opportunities for the growth of the live cell imaging market. This can primarily be attributed to the growing R&D funding for various research organizations in these countries. Currently, China accounts for about 20% of the global R&D spending and is the second-largest investor in R&D, globally, after the US. The country is projected to overtake the US in R&D spending by 2023 (Source: Council on Foreign Relations). Cost savings and a lack of regulations are among the most important drivers boosting preclinical activities in China. The growing funding and investments in life science research, availability of highly skilled personnel, and a favorable regulatory environment are the other major factors supporting this trend. Moreover, currently, China has many CROs that provide preclinical and clinical research services to multinational pharmaceutical companies. The growth of preclinical/clinical research in China is expected to augment the demand for live cell imaging in the country in the coming years. 

Challenges: Maintaining cell viability and the cellular environment in cell cultures

Running live cell imaging experiments successfully can be a major challenge. The conditions under which cells are maintained under microscopes decide the success or failure of the experiment. Therefore, maintaining living cells on slides is the most crucial part of the experiment. The cells used in experiments should be in good condition and function normally under a microscope in the presence of synthetic fluorophores or fluorescent proteins. Additionally, maintaining a constant cellular environment is very important during the experiment; the cells should be grown in culture media in a carbon dioxide incubator. Temperature also plays a crucial role in maintaining cell viability in a culture. Hence, as the cell viability and cellular environment are dependent on several specific requirements, the chances of a live cell imaging experiment being unsuccessful are high. 

Global Live Cell Imaging Market Interconnections

Global Live Cell Imaging Market Interconnections

To know about the assumptions considered for the study, download the pdf brochure

The consumables segment is projected to grow at the highest CAGR during the forecast period

Based on product & service, the global live cell imaging market is segmented into instruments, consumables, software, and services. The consumables segment, on the other hand, is expected to grow at the highest CAGR during the forecast period. The need for the frequent purchase of consumables is expected to play a key role in the growth of the consumables market during the forecast period. 

The pharmaceutical & biotechnology companies segment accounted for the largest share of the live cell imaging market in the year 2019.

Based on end user, the global market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations (CROs). In 2019, pharmaceutical & biotechnology companies segment accounted for the largest share of the global market. The large share of this segment can be attributed to the increasing R&D activities and the patent cliff of various blockbuster drugs. 

The Asia Pacific region is expected to show the highest growth rate during the forecast period.

Geographically, the global live cell imaging market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is expected to show the highest growth rate during the forecast period. The high growth rate of this region can mainly be attributed to the factors such as the government initiatives for research on stem cell therapy, the rising prominence of regenerative medicine research, growth of preclinical/clinical research in China, favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry in India, and growth of the pharmaceutical and biopharmaceutical sectors in South Korea. 

Live Cell Imaging Market By Region

The leading players in this market include Danaher Corporation (US), Carl Zeiss AG (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (US), GE Healthcare (US), Bruker Corporation (US), Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), Oxford Instruments (UK), BioTek Instruments (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), NanoEnTek Inc. (Korea), Phase Focus Limited (UK), Tomocube, Inc. (South Korea), Phase Holographic Imaging PHI AB (Sweden), BD Biosciences (US), Sony Biotechnology, Inc. (US), Merck KGaA (Germany), KEYENCE Corporation (Japan), ibidi GmbH (Germany), Bio-Rad Laboratories (US), Logos Biosystems (South Korea), and Nanolive SA (Switzerland).

Live Cell Imaging Market Report Scope:

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD)

Segments covered

Product & Service, Application, Technology, End User, and Region

Geographies covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Companies covered

Danaher Corporation (US), Carl Zeiss AG (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (US), GE Healthcare (US), Bruker Corporation (US), Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), Oxford Instruments (UK), BioTek Instruments (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), NanoEnTek Inc. (Korea), Phase Focus Limited (UK), Tomocube, Inc. (South Korea), Phase Holographic Imaging PHI AB (Sweden), BD Biosciences (US), Sony Biotechnology, Inc. (US), Merck KGaA (Germany), KEYENCE Corporation (Japan), ibidi GmbH (Germany), Bio-Rad Laboratories (US), Logos Biosystems (South Korea), and Nanolive SA (Switzerland).
Total 25 major players covered

The live cell imaging market research report categorizes the market into the following segments and sub-segments:

By Product & Service

  • Instruments
  • Microscopes
  • Standalone Systems
  • Cell Analyzers
  • Accessories
  • Consumables
  • Reagents
  • Assay Kits
  • Media
  • Other Consumables
  • Software
  • Services 

By Application

  • Cell Biology
  • Stem Cells
  • Developmental Biology
  • Drug Discovery 

By Technology

  • Time-lapse Microscopy
  • Fluorescence Resonance Energy Transfer (FRET)
  • Fluorescence Recovery After Photobleaching (FRAP)
  • High-content Screening (HCS)
  • Other Technologies 

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs) 

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa 

Recent Developments:

  • In September 2020, CytoSMART Technologies (Netherlands) launched CytoSMART Multi Lux, a remote live cell imaging system.
  • In July 2020, Etaluma, Inc. (US) partnered with INNOMED GmbH (Germany) to introduce entry-level incubator cell imaging to the Americas. Through the partnership, Etaluma strengthened its Lumascope offerings.
  • In December 2019, Leica Microsystems (Germany) entered into agreement with European Molecular Biology Laboratory (EMBL) (Germany) to develop new imaging technologies applicable in life science.
  • In April 2019, Nikon Corporation (Japan) launched two new silicone immersion objective lenses—the CFI Plan Apochromat Lambda S 25XC Sil and the CFI Plan Apochromat Lambda S 40XC Sil—for confocal laser microscope systems and Ti2 inverted research microscopes.
  • In July 2018, Bruker Corporation (US) acquired JPK Instruments AG (Germany) to enhance its microscopy offerings. 

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 41)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE 
          FIGURE 1 LIVE CELL IMAGING MARKET SEGMENTATION
           1.3.1 YEARS CONSIDERED
    1.4 CURRENCY 
    1.5 LIMITATIONS 
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
           1.7.1 RECESSION IMPACT
 
2 RESEARCH METHODOLOGY (Page No. - 46)
    2.1 RESEARCH DATA 
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 3 LIVE CELL IMAGING MARKET: BREAKDOWN OF PRIMARIES
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022
          FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
          FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS, 2022
           2.2.1 INSIGHTS FROM PRIMARIES
                    FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS
                    FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    2.3 GROWTH FORECAST 
          FIGURE 9 LIVE CELL IMAGING MARKET: CAGR PROJECTIONS, 2022–2028
          FIGURE 10 LIVE CELL IMAGING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 11 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 RECESSION IMPACT ON LIVE CELL IMAGING MARKET 
          TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
          TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
          TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
 
3 EXECUTIVE SUMMARY (Page No. - 59)
    FIGURE 12 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2023 VS. 2028 (USD MILLION)
    FIGURE 13 LIVE CELL IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    FIGURE 15 LIVE CELL IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 16 GEOGRAPHICAL SNAPSHOT OF LIVE CELL IMAGING MARKET
 
4 PREMIUM INSIGHTS (Page No. - 63)
    4.1 LIVE CELL IMAGING MARKET OVERVIEW 
          FIGURE 17 GROWING ADOPTION OF HIGH-CONTENT SCREENING TECHNIQUES IN DRUG DISCOVERY TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: LIVE CELL IMAGING MARKET SHARE,  BY PRODUCT & SERVICE AND COUNTRY (2022) 
          FIGURE 18 INSTRUMENTS DOMINATED NORTH AMERICAN LIVE CELL IMAGING  MARKET IN 2022
    4.3 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2023 VS. 2028 (USD MILLION) 
          FIGURE 19 INSTRUMENTS TO CONTINUE TO DOMINATE MARKET BY 2028
    4.4 LIVE CELL IMAGING MARKET SHARE, BY END USER, 2022 
          FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
    4.5 LIVE CELL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN LIVE CELL IMAGING MARKET FROM 2023 TO 2028
 
5 MARKET OVERVIEW (Page No. - 67)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 22 LIVE CELL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 4 LIVE CELL IMAGING MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Growing adoption of high-content screening techniques in drug discovery
                    5.2.1.2 Rising incidence of cancer
                                TABLE 5 ESTIMATED NEW CANCER CASES IN US, 2023
                                FIGURE 23 GLOBAL CANCER INCIDENCE & MORTALITY, 2020
                    5.2.1.3 Growing availability of research funds
                                TABLE 6 INVESTMENT BREAKDOWN, 2021 (USD MILLION)
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of high-content screening systems
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing adoption of live cell imaging technologies in emerging economies
                    5.2.3.2 Applications of HCS in personalized medicine
           5.2.4 CHALLENGES
                    5.2.4.1 Maintaining cell viability and cellular environment in cell cultures
                    5.2.4.2 Image analysis and data management
    5.3 TECHNOLOGY ANALYSIS 
    5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
          FIGURE 24 REVENUE SHIFT & NEW POCKETS FOR LIVE CELL IMAGING PRODUCT & SERVICE PROVIDERS
    5.5 VALUE/SUPPLY CHAIN ANALYSIS 
           5.5.1 VALUE CHAIN ANALYSIS
                    FIGURE 25 LIVE CELL IMAGING MARKET: VALUE CHAIN ANALYSIS
           5.5.2 SUPPLY CHAIN ANALYSIS
                    FIGURE 26 LIVE CELL IMAGING MARKET: SUPPLY CHAIN ANALYSIS
    5.6 REGULATORY ANALYSIS 
           5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    5.6.1.1 North America
                               5.6.1.1.1 US
                               5.6.1.1.2 Canada
                    5.6.1.2 Europe
                    5.6.1.3 Asia Pacific
                    5.6.1.4 Rest of the World
    5.7 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 7 LIVE CELL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.7.1 THREAT OF NEW ENTRANTS
           5.7.2 THREAT OF SUBSTITUTES
           5.7.3 BARGAINING POWER OF SUPPLIERS
           5.7.4 BARGAINING POWER OF BUYERS
           5.7.5 INTENSITY OF COMPETITIVE RIVALRY
    5.8 ECOSYSTEM ANALYSIS 
          TABLE 8 SUPPLY CHAIN ECOSYSTEM
    5.9 PRICING ANALYSIS 
           5.9.1 AVERAGE SELLING PRICE, BY KEY PLAYER
                    TABLE 9 AVERAGE SELLING PRICES
           5.9.2 AVERAGE SELLING PRICE TREND
    5.10 KEY CONFERENCES & EVENTS IN 2022–2023 
           TABLE 10 LIVE CELL IMAGING: DETAILED LIST OF CONFERENCES & EVENTS
    5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF LIVE CELL IMAGING PRODUCTS
           5.11.2 BUYING CRITERIA FOR LIVE CELL IMAGING
                     FIGURE 28 KEY BUYING CRITERIA FOR END USERS
    5.12 PATENT ANALYSIS 
           FIGURE 29 LIVE CELL IMAGING MARKET: PATENT APPLICATIONS  (JANUARY 2020–APRIL 2023)
 
6 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE (Page No. - 90)
    6.1 INTRODUCTION 
          TABLE 11 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
    6.2 INSTRUMENTS 
          TABLE 12 EXAMPLES OF INSTRUMENTS OFFERED BY MARKET PLAYERS
          TABLE 13 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 14 LIVE CELL IMAGING INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 15 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 16 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 17 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 18 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
           6.2.1 MICROSCOPES
                    6.2.1.1 Continuous technological advancements in microscopes to support market
                                TABLE 19 CONVENTIONAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS
                                TABLE 20 CONFOCAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS
                                TABLE 21 FLUORESCENCE MICROSCOPES OFFERED BY KEY MARKET PLAYERS
                                TABLE 22 LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY REGION,  2021–2028 (USD MILLION)
                                TABLE 23 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 24 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 25 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES,  BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 26 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES,  BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.2 STANDALONE SYSTEMS
                    6.2.2.1 Seamless integration and workflow efficiency of standalone systems to boost demand
                                TABLE 27 STANDALONE SYSTEMS OFFERED BY KEY MARKET PLAYERS
                                TABLE 28 LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 29 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 30 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS,  BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 31 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 32 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.3 CELL ANALYZERS
                    6.2.3.1 Accuracy and reproducibility of cell analyzers to support growth
                                TABLE 33 CELL ANALYZERS OFFERED BY KEY MARKET PLAYERS
                                TABLE 34 LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY REGION,  2021–2028 (USD MILLION)
                                TABLE 35 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS,  BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 36 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS,  BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 37 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS,  BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 38 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS,  BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.4 ACCESSORIES
                    6.2.4.1 Ability of accessories to optimize and enhance imaging conditions to boost demand
                                TABLE 39 ACCESSORIES OFFERED BY KEY MARKET PLAYERS
                                TABLE 40 LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY REGION,  2021–2028 (USD MILLION)
                                TABLE 41 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES,  BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 42 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 43 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES,  BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 44 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES,  BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 CONSUMABLES 
          TABLE 45 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 46 LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 47 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 48 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 49 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 50 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
           6.3.1 REAGENTS
                    6.3.1.1 Widespread usage in life science research to fuel market growth
                                TABLE 51 REAGENTS OFFERED BY KEY MARKET PLAYERS
                                TABLE 52 LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY REGION,  2021–2028 (USD MILLION)
                                TABLE 53 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS,  BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 54 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 55 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS,  BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 56 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS,  BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.2 ASSAY KITS
                    6.3.2.1 Repeat purchase of assay kits to drive market
                                TABLE 57 ASSAY KITS OFFERED BY KEY MARKET PLAYERS
                                TABLE 58 LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY REGION,  2021–2028 (USD MILLION)
                                TABLE 59 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS,  BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 60 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS,  BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 61 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS,  BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 62 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS,  BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.3 MEDIA
                    6.3.3.1 Increasing demand for optimized cell culture conditions to drive demand for media
                                TABLE 63 MEDIA OFFERED BY KEY MARKET PLAYERS
                                TABLE 64 LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY REGION,  2021–2028 (USD MILLION)
                                TABLE 65 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA,  BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 66 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 67 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 68 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA,  BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.4 OTHER CONSUMABLES
                    TABLE 69 OTHER CONSUMABLES OFFERED BY KEY MARKET PLAYERS
                    TABLE 70 OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 71 NORTH AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 72 EUROPE: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 73 ASIA PACIFIC: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 74 LATIN AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
    6.4 SOFTWARE 
           6.4.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGE ACQUISITION TO BOOST MARKET GROWTH
                    TABLE 75 SOFTWARE OFFERED BY KEY MARKET PLAYERS
                    TABLE 76 LIVE CELL IMAGING SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 77 NORTH AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 78 EUROPE: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 79 ASIA PACIFIC: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 80 LATIN AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
    6.5 SERVICES 
           6.5.1 GROWING DEMAND FOR OUTSOURCED EXPERTISE AND SPECIALIZED SERVICES TO SUPPORT MARKET
                    TABLE 81 LIVE CELL IMAGING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 82 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 83 EUROPE: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 84 ASIA PACIFIC: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 85 LATIN AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
 
7 LIVE CELL IMAGING MARKET, BY APPLICATION (Page No. - 127)
    7.1 INTRODUCTION 
          TABLE 86 LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
    7.2 CELL BIOLOGY 
          TABLE 87 NUMBER OF NEW CANCER CASES, BY TYPE, 2020 VS. 2040
          TABLE 88 LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY REGION,  2021–2028 (USD MILLION)
          TABLE 89 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 90 EUROPE: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 91 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 92 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 STEM CELLS 
           7.3.1 GROWING FOCUS ON REGENERATIVE MEDICINE & ADVANCEMENTS IN STEM CELL RESEARCH TO BOOST MARKET
                    TABLE 93 LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 94 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 95 EUROPE: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 96 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 97 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
    7.4 DEVELOPMENTAL BIOLOGY 
           7.4.1 GROWING INTEREST IN UNDERSTANDING ORGANOGENESIS AND TISSUE MORPHOGENESIS TO DRIVE DEMAND
                    TABLE 98 LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 99 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 100 EUROPE: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 101 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 102 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.5 DRUG DISCOVERY 
           7.5.1 GROWING USE OF HCS CELL-BASED ASSAYS IN DRUG DISCOVERY STUDIES TO DRIVE DEMAND
                    TABLE 103 LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 104 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 105 EUROPE: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 106 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 107 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
 
8 LIVE CELL IMAGING MARKET, BY TECHNOLOGY (Page No. - 139)
    8.1 INTRODUCTION 
          TABLE 108 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
    8.2 TIME-LAPSE MICROSCOPY 
          TABLE 109 LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY REGION,  2021–2028 (USD MILLION)
          TABLE 110 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY,  BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 111 EUROPE: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 112 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 113 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY,  BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) 
           8.3.1 ADVANCEMENTS IN FLUORESCENT MATERIALS AND PROBES TO BOOST ADOPTION OF FRET TECHNOLOGY
                    TABLE 114 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER,  BY REGION, 2021–2028 (USD MILLION)
                    TABLE 115 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 116 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 117 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 118 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP) 
           8.4.1 INTEGRATION OF FRAP WITH LIVE CELL IMAGING MICROSCOPY TO CONTRIBUTE TO MARKET GROWTH
                    TABLE 119 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 120 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 121 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 122 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 123 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)
    8.5 HIGH-CONTENT SCREENING (HCS) 
           8.5.1 GROWING ADOPTION OF HCS IN DRUG DISCOVERY AND TOXICITY SCREENING TO DRIVE GROWTH
                    TABLE 124 LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 125 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 126 EUROPE: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 127 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 128 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING,  BY COUNTRY, 2021–2028 (USD MILLION)
    8.6 OTHER TECHNOLOGIES 
          TABLE 129 LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY REGION,  2021–2028 (USD MILLION)
          TABLE 130 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES,  BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 131 EUROPE: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 132 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 133 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
 
9 LIVE CELL IMAGING MARKET, BY END USER (Page No. - 152)
    9.1 INTRODUCTION 
          TABLE 134 LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
    9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
           9.2.1 NEED TO ADHERE TO STRICT REGULATIONS TO DRIVE USE OF LIVE CELL IMAGING PRODUCTS AMONG PHARMA COMPANIES
                    TABLE 135 LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,  BY REGION, 2021–2028 (USD MILLION)
                    TABLE 136 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 137 EUROPE: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 138 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 139 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
    9.3 ACADEMIC & RESEARCH INSTITUTES 
           9.3.1 INCREASING NUMBER OF DRUG DISCOVERY RESEARCH PROGRAMS TO DRIVE MARKET GROWTH
                    TABLE 140 LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 141 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 142 EUROPE: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 143 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 144 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
    9.4 CONTRACT RESEARCH ORGANIZATIONS 
           9.4.1 GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE DEMAND
                    TABLE 145 LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 146 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 147 EUROPE: LIVE CELL IMAGING MARKET FOR F CONTRACT RESEARCH ORGANIZATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 148 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 149 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
 
10 LIVE CELL IMAGING MARKET, BY REGION (Page No. - 161)
     10.1 INTRODUCTION 
             TABLE 150 LIVE CELL IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION)
     10.2 NORTH AMERICA 
             FIGURE 30 NORTH AMERICA: LIVE CELL IMAGING MARKET SNAPSHOT
             TABLE 151 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 152 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
             TABLE 153 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 154 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 155 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
             TABLE 156 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
             TABLE 157 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER,  2021–2028 (USD MILLION)
             10.2.1 US
                        10.2.1.1 US to dominate live cell imaging market in North America
                                      TABLE 158 US: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 159 US: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 160 US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 161 US: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 162 US: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 163 US: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Government initiatives to promote research to support market growth
                                      TABLE 164 CANADA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 165 CANADA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 166 CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 167 CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 168 CANADA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 169 CANADA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.2.3 NORTH AMERICA: RECESSION IMPACT
     10.3 EUROPE 
             TABLE 170 EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 171 EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
             TABLE 172 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 173 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 174 EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 175 EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
             TABLE 176 EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Presence of large number of academic research institutes to boost market
                                      TABLE 177 GERMANY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 178 GERMANY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 179 GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 180 GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 181 GERMANY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 182 GERMANY: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Investments by pharmaceutical sponsors for drug discovery services to support market
                                      FIGURE 31 UK: PHARMACEUTICAL R&D EXPENDITURE, 2011–2020 (USD MILLION)
                                      TABLE 183 UK: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 184 UK: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 185 UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 186 UK: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 187 UK: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 188 UK: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Large pharmaceutical manufacturing industry to drive market growth
                                      TABLE 189 FRANCE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 190 FRANCE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 191 FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 192 FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 193 FRANCE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 194 FRANCE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Strong research tradition, government funding, and collaborative research networks to fuel growth
                                      TABLE 195 ITALY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 196 ITALY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 197 ITALY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 198 ITALY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 199 ITALY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 200 ITALY: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Rising R&D expenditure to boost market
                                      TABLE 201 SPAIN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 202 SPAIN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 203 SPAIN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 204 SPAIN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 205 SPAIN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 206 SPAIN: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.3.6 REST OF EUROPE
                        TABLE 207 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                        TABLE 208 REST OF EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 209 REST OF EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 210 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                        TABLE 211 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
                        TABLE 212 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY END USER,  2021–2028 (USD MILLION)
             10.3.7 EUROPE: RECESSION IMPACT
     10.4 ASIA PACIFIC 
             TABLE 213 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 214 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
             TABLE 215 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 216 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 217 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 218 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
             TABLE 219 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.1 CHINA
                        10.4.1.1 China to dominate APAC live cell imaging market
                                      TABLE 220 CHINA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 221 CHINA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 222 CHINA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 223 CHINA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 224 CHINA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 225 CHINA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.2 JAPAN
                        10.4.2.1 Rising prominence of regenerative medicine research to drive market growth
                                      TABLE 226 JAPAN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 227 JAPAN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 228 JAPAN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 229 JAPAN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 230 JAPAN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 231 JAPAN: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Growing pharmaceutical industry to create favorable opportunities for market players
                                      TABLE 232 INDIA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 233 INDIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 234 INDIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 235 INDIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 236 INDIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 237 INDIA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC (ROAPAC)
                        TABLE 238 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                        TABLE 239 REST OF ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 240 REST OF ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 241 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                        TABLE 242 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
                        TABLE 243 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER,  2021–2028 (USD MILLION)
             10.4.5 ASIA PACIFIC: RECESSION IMPACT
     10.5 LATIN AMERICA 
             TABLE 244 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 245 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
             TABLE 246 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 247 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 248 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
             TABLE 249 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
             TABLE 250 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.5.1 BRAZIL
                        10.5.1.1 Gradual growth in research to contribute to growth
                                      TABLE 251 BRAZIL: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 252 BRAZIL: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 253 BRAZIL: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 254 BRAZIL: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 255 BRAZIL: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 256 BRAZIL: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
             10.5.2 REST OF LATIN AMERICA
                        TABLE 257 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                        TABLE 258 REST OF LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 259 REST OF LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 260 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                        TABLE 261 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
                        TABLE 262 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER,  2021–2028 (USD MILLION)
             10.5.3 LATIN AMERICA: RECESSION IMPACT
     10.6 MIDDLE EAST & AFRICA 
             10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH
                        TABLE 263 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                        TABLE 264 MIDDLE EAST & AFRICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 265 MIDDLE EAST & AFRICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 266 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                        TABLE 267 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)
                        TABLE 268 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY END USER,  2021–2028 (USD MILLION)
             10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
 
11 COMPETITIVE LANDSCAPE (Page No. - 226)
     11.1 INTRODUCTION 
     11.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 32 LIVE CELL IMAGING MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
     11.3 REVENUE SHARE ANALYSIS 
             FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
     11.4 MARKET SHARE ANALYSIS 
             FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
             TABLE 269 LIVE CELL IMAGING MARKET: DEGREE OF COMPETITION
     11.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS 
             FIGURE 35 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX  FOR KEY PLAYERS, 2022
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
     11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 
             11.6.1 END-USER FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 270 END-USER FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET
             11.6.2 PRODUCT & SERVICE FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 271 PRODUCT & SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET
             11.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 272 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET
     11.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES 
             FIGURE 36 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
             11.7.1 PROGRESSIVE COMPANIES
             11.7.2 STARTING BLOCKS
             11.7.3 RESPONSIVE COMPANIES
             11.7.4 DYNAMIC COMPANIES
     11.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 
             TABLE 273 LIVE CELL IMAGING MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
             TABLE 274 LIVE CELL IMAGING MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
     11.9 COMPETITIVE SCENARIO AND TRENDS 
             11.9.1 PRODUCT LAUNCHES
                        TABLE 275 LIVE CELL IMAGING MARKET: PRODUCT LAUNCHES, JANUARY 2020–DECEMBER 2022
             11.9.2 DEALS
                        TABLE 276 LIVE CELL IMAGING MARKET: DEALS, JANUARY 2020–DECEMBER 2022
             11.9.3 OTHER DEVELOPMENTS
                        TABLE 277 LIVE CELL IMAGING MARKET: OTHER DEVELOPMENTS, JANUARY 2020–DECEMBER 2022
 
12 COMPANY PROFILES (Page No. - 242)
     12.1 KEY COMPANIES 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             12.1.1 DANAHER
                        TABLE 278 DANAHER: BUSINESS OVERVIEW
                        FIGURE 37 DANAHER: COMPANY SNAPSHOT (2022)
             12.1.2 ZEISS GROUP
                        TABLE 279 ZEISS GROUP: BUSINESS OVERVIEW
                        FIGURE 38 ZEISS GROUP: COMPANY SNAPSHOT (2022)
             12.1.3 SARTORIUS AG
                        TABLE 280 SARTORIUS AG: BUSINESS OVERVIEW
                        FIGURE 39 SARTORIUS AG: COMPANY SNAPSHOT (2022)
             12.1.4 THERMO FISHER SCIENTIFIC, INC.
                        TABLE 281 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
                        FIGURE 40 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
             12.1.5 OLYMPUS CORPORATION
                        TABLE 282 OLYMPUS CORPORATION: BUSINESS OVERVIEW
                        FIGURE 41 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
             12.1.6 PERKINELMER INC.
                        TABLE 283 PERKINELMER INC.: BUSINESS OVERVIEW
                        FIGURE 42 PERKINELMER INC.: COMPANY SNAPSHOT (2023)
             12.1.7 NIKON CORPORATION
                        TABLE 284 NIKON CORPORATION: BUSINESS OVERVIEW
                        FIGURE 43 NIKON CORPORATION: COMPANY SNAPSHOT (2022)
             12.1.8 ETALUMA, INC.
                        TABLE 285 ETALUMA, INC.: BUSINESS OVERVIEW
             12.1.9 CYTOSMART TECHNOLOGIES
                        TABLE 286 CYTOSMART TECHNOLOGIES.: BUSINESS OVERVIEW
             12.1.10 AGILENT TECHNOLOGIES, INC.
                        TABLE 287 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
                        FIGURE 44 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
             12.1.11 NANOENTEK INC.
             12.1.12 BECTON, DICKINSON AND COMPANY
                        TABLE 288 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
                        FIGURE 45 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
             12.1.13 GE HEALTHCARE
                        TABLE 289 GE HEALTHCARE: BUSINESS OVERVIEW
                        FIGURE 46 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
             12.1.14 BRUKER CORPORATION
                        TABLE 290 BRUKER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 47 BRUKER CORPORATION: COMPANY SNAPSHOT (2022)
             12.1.15 MERCK KGAA
                        TABLE 291 MERCK KGAA: BUSINESS OVERVIEW
                        FIGURE 48 MERCK KGAA: COMPANY SNAPSHOT (2022)
             12.1.16 BIO-RAD LABORATORIES, INC.
                        TABLE 292 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
                        FIGURE 49 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
             12.1.17 CORNING INCORPORATED
                        TABLE 293 CORNING INCORPORATED: BUSINESS OVERVIEW
                        FIGURE 50 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
     12.2 OTHER PLAYERS 
             12.2.1 BLUE-RAY BIOTECH CORP.
             12.2.2 CYTENA GMBH
             12.2.3 NANOLIVE SA
             12.2.4 ABBERIOR
             12.2.5 PHASE HOLOGRAPHIC IMAGING PHI AB
             12.2.6 CYTOSKELETON, INC.
             12.2.7 KEYENCE CORPORATION
             12.2.8 ALIGNED GENETICS, INC.
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
13 APPENDIX (Page No. - 297)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

The study involved four major activities in estimating the size of the live cell imaging market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments. 

Secondary Research

In the secondary research process, various sources such Microscopy Society of America (MSA), European Microscopy Society (EMS), Australian Microscopy and Microanalysis Society (AMMS), American Society for Cell Biology (ASCB), World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), and Centers for Disease Control and Prevention (CDC) among others, as well as the Annual Reports/SEC Filings, Investor Presentations of various companies, and the press releases of critical players (white papers; journals/magazines; and news articles) were considered. 

Primary Research

In the primary research process, industry experts from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Industry experts from the supply side include CEOs, vice presidents, marketing and sales directors, product managers, business development managers, technology and innovation directors of companies providing live cell imaging products, key opinion leaders, and suppliers and distributors. The industry experts from the demand side include academic researchers, cell culture specialists, and R&D professionals from pharmaceutical & biotechnology companies. 

Following the breakdown of primary respondents-

Live Cell Imaging Market Size

To know about the assumptions considered for the study, download the pdf brochure

Note 1: C-level primaries include CEOs, COOs, CTOs, VPs, and AVPs.

 2: Others include sales managers, marketing managers, and product managers.

 3: Tiers of the companies are defined according to their revenues. As of 2019: Tier 1 = >USD 1 billion, Tier 2 = USD 100 million to USD 1 billion, and Tier 3 = < USD 100 million. <>

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by product & service, by application, by technology, end user, and region). 

Bottom-up Approach

In this report, the global live cell imaging market size was arrived by obtaining revenues for individual companies through public sources and databases. Shares of leading players in the live cell imaging market were gathered from secondary sources to the extent available. In some instances, the shares of the live cell imaging  businesses have been ascertained after a detailed analysis of various parameters, including the product portfolio, market positioning, selling price, and geographic reach and strength, among others. Wherever feasible, revenue share analysis was also employed to arrive at segmental market sizes, by identifying leading players in respective product categories. 

Bottom-up Approach

Live Cell Imaging Market Bottom Up Approach

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach

Individual shares of each product segment were arrived at by assigning weightages based on their utilization/adoption rate. Regional splits of the overall live cell imaging market and its sub-segments are based on the adoption or utilization rates of the given products in respective regions or countries. For countries with limited availability of reliable and recent data, analogy/benchmarking-based market estimation and forecast technique was used. 

Data Triangulation

After arriving at the market size, the total live cell imaging market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.                                                        

Report Objectives

  • To define, describe, and forecast the global live cell imaging market by product, application, technology, end user, and region
  • To provide detailed information about the factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the live cell imaging market in five regions (along with major countries)—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
  • To profile key players in the live cell imaging market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as acquisitions; new product/technology launches; collaborations, partnerships, and agreements; and expansions of the leading players in the global live cell imaging market 

Available customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report: 

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific live cell imaging market into Australia, South Korea, and other countries
  • Further breakdown of the Rest of Europe live cell imaging market into Italy, Spain, Russia, the Netherlands, Switzerland, and other countries

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
Report Code
BT 3390
Published ON
Oct, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Live Cell Imaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback